Skip to main content
Caplight Logo









Entact Bio

Entact Bio

Private
Watertown, MassachusettsHealthcare & Life Scienceshttps://entactbio.com/

Last Round

Seed Round

Jun 3, 2026

Total Funding Raised

$121.3M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Entact Bio is a biotechnology company that develops small-molecule drugs called ENTACs to enhance the function of beneficial proteins through natural cellular mechanisms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

protein enhancementdrug discoverybiotechbiotechnologysmall molecule drugsdrug developmentprotein therapeuticstherapeutic platformprotein upregulationpreclinical researchtarget discoverycomputational biologypharma partnershipsprotein degradation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Entact Bio Comparables

Compare Entact Bio with similar companies based on industry and business-model similarity.

Entact Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Stablix
86%
Vicinitas Therapeutics
82%
Outrun Therapeutics
77%

Entact Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJun 3, 2026
Series A ExtensionJan 17, 2024
Series ADec 6, 2022
SeedOct 1, 2019

Key People

Founding team and executive leadership

Victoria Richon

Chief Executive Officer

Executive Team

Entact Bio Investors

Notable investors and investment history

Entact Bio investors
InvestorRounds
Surveyor CapitalSeries A
Janus Henderson GroupSeries A
4BIO CapitalSeries A, Seed
Logos CapitalSeries A
AbingworthSeries A
Arkin HoldingsSeries A
CitadelSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 3, 2026

    $10M raised in Seed Round.

  • Dec 6, 2022

    $81M round led by Qiming

Entact Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Entact Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Entact Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersWatertown, Massachusetts
Employee Range21
Year Founded2019
Last FundingJun 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?